Oral cancer drugs have become significantly more expensive compared with those from 15 years ago, according to a new study. The research provides insight into rising drug prices in the U.S., particularly among specialty medications. Credit : Jonathan Silverberg/Flick

Oral cancer drugs have become significantly more expensive compared with those from 15 years ago, according to a new study. The research provides insight into rising drug prices in the U.S., particularly among specialty medications.
Credit : Jonathan Silverberg/Flick

New cancer pills have become significantly more expensive upon their market entry compared with those from 15 years ago. These high introductory prices prove to be a cause of concern given that medication costs rapidly climb over time.

The average cost of orally administered cancer treatments has risen dramatically — six times more than those introduced in 2000 — even after prices were adjusted for inflation. Those drugs from more than a decade earlier cost $1,869 a month on average, compared to the $11,325 for those approved in 2014. (emphasis added)

“The major trend here is that these products are just […]

Read the Full Article